GSK

FDA approves GSK’s Voltaren Arthritis Pain for over-the-counter use in the US
Pharmaceutical Business Review
Tue, 02/18/20 - 10:24 am
GSK
Voltaren
arthritis
NSAID
OTC
FDA
FDA Speeds Up Examination of 5 Drugs with Priority Review
BioSpace
Thu, 02/13/20 - 12:24 am
FDA
priority review
capmatinib
Kite Pharma
KTE-X19
Eli Lilly
selpercatinib
GSK
belantamab mafodotin
Astex
C-DEC
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
BioSpace
Mon, 02/10/20 - 10:19 am
earnings
Bristol-Myers Squibb
AbbVie
Novo Nordisk
Merck
GSK
Seattle Genetics
GSK cutting 720 jobs in manufacturing, R&D and support functions at massive Belgian vaccine hub
Fierce Pharma
Thu, 02/6/20 - 11:53 am
GSK
vaccines
layoffs
restructuring
Belgium
GSK profit falls short as cheap competition hits older drugs
Reuters
Wed, 02/5/20 - 09:54 pm
GSK
earnings
GlaxoSmithKline's spinoff plan is here—and it may not be limited to consumer health
Fierce Pharma
Wed, 02/5/20 - 10:12 am
GSK
spinoffs
Emma Walmsley
consumer health
dermatology
R&D
Former GSK Site in Pennsylvania Gets Revamped into Life Sciences Hub
BioSpace
Mon, 02/3/20 - 11:45 pm
GSK
Discovery Labs
R&D
Pennsylvania
British drugmaker GSK to collaborate with CEPI in effort to develop coronavirus vaccine
Reuters
Sun, 02/2/20 - 11:56 pm
GSK
vaccines
CEPI
coronaviruses
Wuhan Coronavirus
R&D
GSK, Pfizer and more sign on for Accenture, Google's new data platform
Fierce Pharma
Thu, 01/30/20 - 10:45 am
GSK
Pfizer
Accenture
cloud platforms
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Wed, 01/29/20 - 11:55 pm
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen
GSK hands TB vaccine to Gates Foundation's nonprofit biotech
Fierce Biotech
Mon, 01/27/20 - 10:52 am
GSK
tuberculosis
vaccines
Bill Gates
Gates Foundation
M72/AS01E
GSK bets on tech to help boost lagging R&D as it looks to start 23andMe trial
Fierce Biotech
Wed, 01/22/20 - 11:10 am
GSK
23andMe
R&D
Emma Walmsley
GSK nabs speedy review for one of its top prospects
Fierce Biotech
Tue, 01/21/20 - 11:46 am
GSK
FDA
priority review
BCMA
belantamab mafodotin
relapsed or refractory multiple myeloma
GlaxoSmithKline halts Excedrin production over manufacturing stumble
Fierce Pharma
Tue, 01/21/20 - 11:35 am
GSK
consumer health
Pfizer
Excederin
drug manufacturing
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
JPM: Glaxo sees enormous Shingrix potential, but a supply gap still stands in the way
Fierce Pharma
Thu, 01/16/20 - 12:22 pm
GSK
vaccines
Shingrix
shingles
drug shortages
JPMHC 2020
GSK, Pfizer contradict on the future of consumer health JV — report
Endpoints
Thu, 01/16/20 - 10:03 am
GSK
Pfizer
consumer health
JPMHC 2020
GSK’s CEO Walmsley aiming for six new approvals in 2020
Pharmaforum
Tue, 01/14/20 - 10:07 am
GSK
Pharma CEOs
Emma Walmsley
JPMHC 2020
Zejula
Trelegy
daprodustat
belantamab mafodotin
AZ and Merck, racing against Glaxo, nab Lynparza 'priority' boost in ovarian cancer
Fierce Pharma
Mon, 01/13/20 - 11:49 pm
AstraZeneca
Merck
GSK
Lynparza
ovarian cancer
FDA
priority review
Zejula
GSK's plan to take over the HIV drug market hasn't worked out
BioPharma Dive
Mon, 01/6/20 - 11:47 pm
GSK
FDA
HIV
Dovato
Biktarvy
ViiV Healthcare
Gilead Sciences

Pages